An elucidation of neutrophil functions against mycobacterium tuberculosis infection

Clinical and Developmental Immunology

Volumn 2013, Issue , 2013, Pages

  Morris, Devin ^a   Nguyen, Thien ^a   Kim, John ^a   Kassissa, Christine ^a   Khurasany, Melissa ^a   Luong, Jennifer ^a   Kasko, Sarah ^a   Pandya, Shalin ^a   Chu, Michael ^a   Chi, Po Ting ^a   Ly, Judy ^a   Lagman, Minette ^a   Venketaraman, Vishwanath ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; FREE RADICAL; GLUTATHIONE; INTERLEUKIN 6; LIPOSOME; MALONALDEHYDE; TUMOR NECROSIS FACTOR ALPHA;

ACIDIFICATION; ARTICLE; BACTERIAL GROWTH; CELL VIABILITY; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKOCYTE FUNCTION; LYSOSOME; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NONHUMAN; NORMAL HUMAN; OXIDATIVE STRESS; PHAGOSOME; PRIORITY JOURNAL; TUBERCULOSIS; BIOSYNTHESIS; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MICROBIOLOGY;

ACETYLCYSTEINE; FREE RADICALS; GLUTATHIONE; HUMANS; INTERLEUKIN-6; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHILS; PHAGOSOMES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84888860073     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2013/959650     Document Type: Article

References (40)

1. World Health Organization, Tuberculosis. http://www.who.int/tb/ publications/factsheet-global.pd
2. Tiemersma E. W., van der Werf M. J., Borgdorff M. W., Williams B. G., Nagelkerke N. J. D., Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS ONE 2011 6 4 2-s2.0-79953728493 10.1371/journal.pone.0017601 e17601
3. Goren M. B., D'Arcy Hart P., Young M. R., Armstrong J. A., Prevention of phagosome lysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America 1976 73 7 2510 2514 2-s2.0-0000432690
4. Eum S.-Y., Kong J.-H., Hong M.-S., Lee Y.-J., Kim J.-H., Hwang S.-H., Cho S.-N., Via L. E., Barry C. E. III, Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest 2010 137 1 122 128 2-s2.0-74949135138 10.1378/chest.09-0903
5. Sugawara I., Udagawa T., Yamada H., Rat neutrophils prevent the development of tuberculosis. Infection and Immunity 2004 72 3 1804 1806 2-s2.0-1342302446 10.1128/IAI.72.3.1804-1806.2004 (Pubitemid 38263807)
6. Seiler P., Aichele P., Raupach B., Odermatt B., Steinhoff U., Kaufmann S. H. E., Rapid neutrophil response controls fast-replicating intracellular bacteria but not slow-replicating Mycobacterium tuberculosis. Journal of Infectious Diseases 2000 181 2 671 680 2-s2.0-0034090797 10.1086/315278 (Pubitemid 30131838)
7. Griffith O. W., Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radical Biology and Medicine 1999 27 9-10 922 935 2-s2.0-0033231162 10.1016/S0891-5849(99)00176-8 (Pubitemid 29507466)
8. Buhl R., Jaffe H. A., Holroyd K. J., Mastrangeli A., Cantin A. M., Wells F. B., Saltini C., Crystal R. G., Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. The Lancet 1989 2 8675 1294 1298 2-s2.0-0024378711 (Pubitemid 20005670)
9. de Quay B., Malinverni R., Lauterburg B. H., Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine. AIDS 1992 6 8 815 819 2-s2.0-0026741271
10. Eck H.-P., Gmunder H., Hartmann M., Petzoldt D., Daniel V., Droge W., Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biological Chemistry Hoppe-Seyler 1989 370 2 101 108 2-s2.0-0024595926 (Pubitemid 19068079)
11. Helbling B., von Overbeck J., Lauterburg B. H., Decreased release of glutathione into the systemic circulation of patients with HIV infection. European Journal of Clinical Investigation 1996 26 1 38 44 2-s2.0-0030043194 (Pubitemid 26048693)
12. Klein M., Jarosova K., Forejtova S., Becvar R., Sedova L., Pavelka K., Simkova G., Svobodova R., Hviscova K., Mann H., Putova I., Vencovsky J., Quantiferon T. B., Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents. Clinical and Experimental Rheumatology 2013 31 1 111 117
13. Guerra C., Morris D., Sipin A., Kung S., Franklin M., Gray D., Tanzil M., Guilford F., Khasawneh F. T., Venketaraman V., Glutathione and adaptive immune responses against Mycobacterium tuberculosis infection in healthy and HIV infected individuals. PLoS ONE 2011 6 12 2-s2.0-82555194623 10.1371/journal. pone.0028378 e28378
14. Guerra C., Johal K., Morris D., Moreno S., Alvarado O., Gray D., Tanzil M., Pearce D., Venketaraman V., Control of Mycobacterium tuberculosis growth by activated natural killer cells. Clinical and Experimental Immunology 2012 168 1 142 152 2-s2.0-84857758249 10.1111/j.1365-2249.2011.04552.x
15. Venketaraman V., Dayaram Y. K., Talaue M. T., Connell N. D., Glutathione and nitrosoglutathione in macrophage defense against Mycobacterium tuberculosis. Infection and Immunity 2005 73 3 1886 1889 2-s2.0-15544370682 10.1128/IAI.73.3.1886-1889.2005 (Pubitemid 40470782)
16. Morris D., Guerra C., Khurasany M., Guilford F., Saviola B., Huang Y., Venketaraman V., Glutathione supplementation improves macrophage functions in HIV. Journal of Interferon & Cytokine Research 2013 33 5 270 279 10.1089/jir.2012.0103
17. Venketaraman V., Dayaram Y. K., Amin A. G., Ngo R., Green R. M., Talaue M. T., Mann J., Connell N. D., Role of glutathione in macrophage control of mycobacteria. Infection and Immunity 2003 71 4 1864 1871 2-s2.0-0037378996 10.1128/IAI.71.4.1864-1871.2003 (Pubitemid 36368717)
18. Dayaram Y. K., Talaue M. T., Connell N. D., Venketaraman V., Characterization of a glutathione metabolic mutant of Mycobacterium tuberculosis and its resistance to glutathione and nitrosoglutathione. Journal of Bacteriology 2006 188 4 1364 1372 2-s2.0-32444445544 10.1128/JB.188.4.1364-1372. 2006 (Pubitemid 43228668)
19. Morris D., Guerra C., Donohue C., Oh H., Khurasany M., Venketaraman V., Unveiling the mechanisms for decreased glutathione in individuals with HIV infection. Clinical and Developmental Immunology 2012 2012 2-s2.0-84855602156 10.1155/2012/734125 734125
20. Venketaraman V., Millman A., Salman M., Swaminathan S., Goetz M., Lardizabal A., David Hom D. H., Connell N. D., Glutathione levels and immune responses in tuberculosis patients. Microbial Pathogenesis 2008 44 3 255 261 2-s2.0-38549110678 10.1016/j.micpath.2007.09.002 (Pubitemid 351163525)
21. Russell D. G., Barry C. E. III, Flynn J. L., Tuberculosis: what we don't know can, and does, hurt us. Science 2010 328 5980 852 856 2-s2.0-77952356637 10.1126/science.1184784
22. Keane J., Gershon S., Wise R. P., Mirabile-Levens E., Kasznica J., Schwieterman W. D., Siegel J. N., Braun M. M., Tuberculosis associated with infliximab, a tumor necrosis factor α -neutralizing agent. The New England Journal of Medicine 2001 345 15 1098 1104 2-s2.0-0035846326 10.1056/NEJMoa011110
23. Gómez-Reino J. J., Carmona L., Rodríguez Valverde V., Mola E. M., Montero M. D., Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis and Rheumatism 2003 48 8 2122 2127 2-s2.0-0041653315 10.1002/art.11137 (Pubitemid 36959191)
24. Botha T., Ryffel B., Reactivation of latent tuberculosis infection in TNF-deficient mice. Journal of Immunology 2003 171 6 3110 3118 2-s2.0-0042834294 (Pubitemid 37093534)
25. Ehlers S., Why does tumor necrosis factor targeted therapy reactivate tuberculosis? Journal of Rheumatology 2005 32 74 35 39 2-s2.0-14944352832 (Pubitemid 40365779)
26. Flynn J. L., Goldstein M. M., Chan J., Triebold K. J., Pfeffer K., Lowenstein C. J., Schreiber R., Mak T. W., Bloom B. R., Tumor necrosis factor- α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995 2 6 561 572 2-s2.0-0028979703
27. Kisich K. O., Higgins M., Diamond G., Heifets L., Tumor necrosis factor alpha stimulates killing of Mycobacterium tuberculosis by human neutrophils. Infection and Immunity 2002 70 8 4591 4599 2-s2.0-0036070607 10.1128/IAI.70.8.4591-4599.2002 (Pubitemid 34790972)
28. Askling J., Fored C. M., Brandt L., Baecklund E., Bertilsson L., Cöster L., Geborek P., Jacobsson L. T., Lindblad S., Lysholm J., Rantapää-Dahlqvist S., Saxne T., Romanus V., Klareskog L., Feltelius N., Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Arthritis and Rheumatism 2005 52 7 1986 1992 2-s2.0-22244454407 10.1002/art.21137 (Pubitemid 40994319)
29. MMWR, Tuberculosis associated with blocking agents against tumor necrosis factor-alpha-California, 2002-2003. Morbidity and Mortality Weekly Report 2004 53 68
30. Wallis R. S., Broder M. S., Wong J. Y., Hanson M. E., Beenhouwer D. O., Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clinical Infectious Diseases 2004 38 9 1261 1265 2-s2.0-2342468669 10.1086/383317 (Pubitemid 38608568)
31. Leal I. S., Flórido M., Andersen P., Appelberg R., Interleukin-6 regulates the phenotype of the immune response to a tuberculosis subunit vaccine. Immunology 2001 103 3 375 381 2-s2.0-0034938735 10.1046/j.1365-2567. 2001.01244.x (Pubitemid 32626186)
32. Ladel C. H., Blum C., Dreher A., Reifenberg K., Kopf M., Kaufmann S. H. E., Lethal tuberculosis in interleukin-6-deficient mutant mice. Infection and Immunity 1997 65 11 4843 4849 2-s2.0-0030734571 (Pubitemid 27463266)
33. Appelberg R., Castro A. G., Pedrosa J., Minoprio P., Role of interleukin-6 in the induction of protective T cells during mycobacterial infections in mice. Immunology 1994 82 3 361 364 2-s2.0-0028103903 (Pubitemid 24251616)
34. Okada M., Kita Y., Kanamaru N., Hashimoto S., Uchiyama Y., Mihara M., Inoue Y., Ohsugi Y., Kishimoto T., Sakatani M., Anti-IL-6 receptor antibody causes less promotion of tuberculosis infection than Anti-TNF- α antibody in mice. Clinical and Developmental Immunology 2011 2011 2-s2.0-79959264360 10.1155/2011/404929 404929
35. Rothstein J. L., Lint T. F., Schreiber H., Tumor necrosis factor/cachectin. Induction of hemorrhagic necrosis in normal tissue requires the fifth component of complement (C5). Journal of Experimental Medicine 1988 168 6 2007 2021 2-s2.0-0024210866 (Pubitemid 19020885)
36. Strieter R. M., Kunkel S. L., Bone R. C., Role of tumor necrosis factor- α in disease states and inflammation. Critical Care Medicine 1993 21 10 S447 S463 2-s2.0-0027488676 (Pubitemid 23304335)
37. Buhl R., Vogelmeier C., Critenden M., Hubbard R. C., Hoyt R. F. Jr., Wilson E. M., Cantin A. M., Crystal R. G., Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol. Proceedings of the National Academy of Sciences of the United States of America 1990 87 11 4063 4067 2-s2.0-0025282179 10.1073/pnas.87.11.4063 (Pubitemid 20217981)
38. Roum J. H., Borok Z., McElvaney N. G., Grimes G. J., Bokser A. D., Buhl R., Crystal R. G., Glutathione aerosol suppresses lung epithelial surface inflammatory cell-derived oxidants in cystic fibrosis. Journal of Applied Physiology 1999 87 1 438 443 2-s2.0-0032779834 (Pubitemid 29330711)
39. Skerry C., Harper J., Klunk M., Bishai W. R., Jain S. K., Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas. PLoS ONE 2012 7 6 e39680 10.1371/journal.pone. 0039680
40. Zeevalk G. D., Bernard L. P., Guilford F. T., Liposomal-glutathione provides maintenance of intracellular glutathione and neuroprotection in mesencephalic neuronal cells. Neurochemical Research 2010 35 10 1575 1587 2-s2.0-77957582975 10.1007/s11064-010-0217-0